UnitedHealth Group
14
0
0
13
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
7.1%
1 terminated/withdrawn out of 14 trials
92.9%
+6.4% vs industry average
14%
2 trials in Phase 3/4
23%
3 of 13 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19)
Role: collaborator
Diabetes Data-Assisted Remission Trial (DDART)
Role: collaborator
Clinical and Economic Validation of the ISGPS Definition of PPAP
Role: collaborator
MORE-PC: A 30-day Automated SMS Program to Support Post-discharge Transitions of Care
Role: collaborator
Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals
Role: lead
A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research
Role: lead
Transform Type 2: Examining Meal-Delivery and Education for Diabetes Self-Care
Role: lead
PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine
Role: lead
Community-based Program to Treat Childhood Obesity
Role: lead
Chronic Obstructive Pulmonary Disease (COPD) Dual Therapy Burden of Illness
Role: collaborator
Personalized Back Rx Exercise Program as a Treatment for Discogenic Low Back Pain
Role: collaborator
Diabetes Care Transformation: Diabetes Data Registry and Intensive Remote Monitoring
Role: collaborator
Evaluation of Video On-Demand Programming to Prevent Type 2 Diabetes in Adults
Role: lead
Evaluation of a Commercial Gaming Impact in a Childhood Obesity Intervention
Role: lead
All 14 trials loaded